sr141716 has been researched along with leptin in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (51.85) | 29.6817 |
| 2010's | 13 (48.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bátkai, S; Di Marzo, V; Fezza, F; Goparaju, SK; Járai, Z; Kunos, G; Liu, J; Miura, GI; Palmiter, RD; Sugiura, T; Wang, L | 1 |
| Arnone, M; Delgorge, C; Gonalons, N; Keane, P; Maffrand, JP; Ravinet Trillou, C; Soubrie, P | 1 |
| Arnone, M; Delgorge, C; Menet, C; Ravinet Trillou, C; Soubrié, P | 1 |
| Bari, M; Battista, N; Bisogno, T; Cascio, MG; Di Marzo, V; Finazzi Agrò, A; Fride, E; Maccarrone, M; Mechoulam, R; Suris, R | 1 |
| Bidouard, JP; Cadrouvele, C; Herbert, JM; Janiak, P; Marniquet, X; O'Connor, SE; Poirier, B; Staels, B | 1 |
| Després, JP; Golay, A; Sjöström, L | 1 |
| Friedrich, MJ | 1 |
| Alemany, M; Cabot, C; Fernández-López, JA; Ferrer-Lorente, R | 1 |
| Al-Zaman, Y; Aylwin, S | 1 |
| Aronne, LJ; Neff, LM | 1 |
| Michaelides, M; Piyis, YK; Ramalhete, RC; Thanos, PK; Volkow, ND; Wang, GJ | 1 |
| Galzin, AM; Hall, D; Minehira, K; Poussin, C; Tarussio, D; Thorens, B | 1 |
| Faludi, G; Halmy, L; Purebl, G; Rihmer, Z | 1 |
| Balaraman, R; Chatterjee, A; Jain, MR; Mohapatra, J; Pandya, G; Patel, PR; Sharma, M; Singh, S | 1 |
| Dodd, GT; Luckman, SM; Lutz, B; Mancini, G | 1 |
| Ambudkar, SV; Bátkai, S; Godlewski, G; Kunos, G; Liu, J; Makriyannis, A; Mukhopadhyay, B; Ohnuma, S; Osei-Hyiaman, D; Pickel, J; Tam, J; Vemuri, VK | 1 |
| Cabasino, S; Lazzari, P; Manca, I; Mastinu, A; Pani, L; Sanna, A | 1 |
| Guijarro, A; Jumpertz, R; Krakoff, J; Piomelli, D; Pratley, RE | 1 |
| Boustany-Kari, CM; Gibbons, CP; Jackson, VM; Swick, AG | 1 |
| Cavallo, JS; Chain, DC; Dressler, HM; Economides, KD; Fan, C; Favara, SG; Galzin, AM; Guillot, E; Naimi, S; Palejwala, VA; Pang, Z; Polites, HG; Pruniaux, MP; Schaffer, E; Tocci, MJ; Weinstock, D; Wu, NN; Yamdagni, P; Zhang, X; Zhao, W | 1 |
| Bedros, JR; Medvegy, M; Pados, G; Simonyi, G | 1 |
| Backhouse, K; Bell, JD; Frost, GS; Robertson, MD; Russell-Jones, D; Sarac, I; Shojaee-Moradie, F; Stolinski, M; Thomas, EL; Umpleby, AM; Wright, J | 1 |
| Bellocchio, L; Cannich, A; Cardinal, P; Clark, S; Cota, D; Klugmann, M; Lutz, B; Marsicano, G | 1 |
| Friedman, JM; Li, Z; Schmidt, SF | 1 |
| Baretić, M | 1 |
| Cinar, R; Earley, BJ; Godlewski, G; Jourdan, T; Kunos, G; Szanda, G; Tam, J; Zhou, L | 1 |
| Fu, L; Gu, CW; Han, JH; Wei, LW; Yuan, ZQ; Zhao, MD | 1 |
5 review(s) available for sr141716 and leptin
| Article | Year |
|---|---|
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide | 2008 |
Pharmacotherapy for obesity.
Topics: Amyloid; Anti-Obesity Agents; Appetite Depressants; Body Weight; Chronic Disease; Comorbidity; Cyclobutanes; Exenatide; Gastrointestinal Hormones; Humans; Islet Amyloid Polypeptide; Lactones; Leptin; Metformin; Obesity; Orlistat; Peptides; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Venoms | 2007 |
[Association of obesity and depression].
Topics: Anti-Obesity Agents; Antidepressive Agents; Appetite Depressants; Appetite Regulation; Bipolar Disorder; Circadian Rhythm; Cyclobutanes; Depression; Depressive Disorder, Major; Dietary Carbohydrates; Energy Intake; Ghrelin; Humans; Hypothalamo-Hypophyseal System; Insulin Resistance; Leptin; Obesity; Piperidines; Pituitary-Adrenal System; Pyrazoles; Rimonabant; Seasonal Affective Disorder; Sleep Wake Disorders; Surveys and Questionnaires; Weight Gain; Weight Loss | 2008 |
[The pharmacological treatment of obesity: past, present and future].
Topics: Amides; Anti-Obesity Agents; Anticonvulsants; Antidepressive Agents; Basal Metabolism; Benzazepines; Benzoxazines; Body Mass Index; Bridged Bicyclo Compounds, Heterocyclic; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Combined Modality Therapy; Cyclobutanes; Dexfenfluramine; Fatty Acids; Female; Fenfluramine; Glucagon-Like Peptide 1; Human Growth Hormone; Humans; Intestinal Absorption; Lactones; Leptin; Life Style; Liraglutide; Male; Norepinephrine; Obesity; Obesity, Morbid; Orlistat; Piperidines; Pyrazoles; Pyridines; Receptor, Melanocortin, Type 4; Rimonabant; Satiation; Serotonin; Sodium-Glucose Transport Proteins; Sucrose; Thyroid Hormones | 2012 |
Obesity drug therapy.
Topics: Anti-Obesity Agents; Appetite; Combined Modality Therapy; Comorbidity; Cost-Benefit Analysis; Cyclobutanes; Diabetes Mellitus, Type 2; Diet, Diabetic; Drug Combinations; Exercise Therapy; Fructose; Gastrointestinal Hormones; Humans; Incretins; Insulin; Insulin Secretion; Intestines; Lactones; Leptin; Life Style; Models, Biological; Neuropeptides; Obesity; Orlistat; Phentermine; Phytotherapy; Piperidines; Plant Preparations; Pyrazoles; Rimonabant; Topiramate | 2013 |
2 trial(s) available for sr141716 and leptin
| Article | Year |
|---|---|
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.
Topics: Adiponectin; Adult; Aged; Anti-Obesity Agents; Blood Glucose; Cannabinoid Receptor Antagonists; Cholesterol; Double-Blind Method; Dyslipidemias; Female; Humans; Insulin; Leptin; Male; Metabolic Syndrome; Middle Aged; Obesity; Overweight; Piperidines; Pyrazoles; Rimonabant; Risk Factors; Triglycerides; Weight Loss | 2005 |
Fatty acid flux and oxidation are increased by rimonabant in obese women.
Topics: Adiponectin; Aged; Breath Tests; Cannabinoid Receptor Antagonists; Cholesterol; Diet, Reducing; Energy Intake; Energy Metabolism; Fatty Acids; Female; Humans; Insulin Resistance; Leptin; Lipolysis; Lipoproteins, VLDL; Middle Aged; Obesity; Oxidation-Reduction; Palmitic Acids; Piperidines; Pyrazoles; Rimonabant; Triglycerides; United Kingdom; Weight Loss | 2012 |
20 other study(ies) available for sr141716 and leptin
| Article | Year |
|---|---|
Leptin-regulated endocannabinoids are involved in maintaining food intake.
Topics: Animals; Appetite Regulation; Arachidonic Acids; Cannabinoid Receptor Modulators; Cannabinoids; Cerebellum; Eating; Endocannabinoids; Female; Food; Glycerides; Hypothalamus; Leptin; Lipoprotein Lipase; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Obesity; Phospholipase D; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Cannabinoid; Receptors, Drug; Receptors, Leptin; Rimonabant; Signal Transduction | 2001 |
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice.
Topics: Animals; Binding Sites; Body Weight; Diet; Dietary Fats; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Insulin; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Time Factors | 2003 |
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity.
Topics: Animals; Body Weight; Diet; Dietary Fats; Eating; Energy Intake; Energy Metabolism; Insulin; Insulin Resistance; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Leptin; Recombinant Proteins; Rimonabant; Thinness | 2004 |
Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility.
Topics: Animals; Arachidonic Acids; Benzyl Compounds; Cannabinoid Receptor Modulators; Endocannabinoids; Female; Fertility; Glycerides; Leptin; Lipoprotein Lipase; Mice; Mice, Knockout; Monoacylglycerol Lipases; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Leptin; Rimonabant; Up-Regulation; Uterus | 2005 |
The anti-obesity effect of rimonabant is associated with an improved serum lipid profile.
Topics: Adiponectin; Animals; Anti-Obesity Agents; Blood Glucose; Cholesterol; Cholesterol, HDL; Insulin; Intercellular Signaling Peptides and Proteins; Leptin; Lipids; Male; Mice; Mice, Inbred C57BL; Obesity; Piperidines; Pyrazoles; Rimonabant | 2005 |
Better strategies sought against obesity.
Topics: Adiposity; Anti-Obesity Agents; Cannabinoid Receptor Modulators; Diet Therapy; Humans; Insulin; Insulin Detemir; Insulin, Long-Acting; Leptin; Obesity; Piperidines; Pyrazoles; Rimonabant | 2006 |
Effects of combined oleoyl-estrone and rimonabant on overweight rats.
Topics: Animals; Anti-Obesity Agents; Appetite; Blood Glucose; Cholecystokinin; Cholesterol; Drug Synergism; Drug Therapy, Combination; Eating; Energy Metabolism; Estrone; Fatty Acids, Nonesterified; Ghrelin; Glucagon-Like Peptide 1; Insulin; Leptin; Male; Obesity; Oleic Acids; Overweight; Peptide Hormones; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant; Triglycerides | 2007 |
Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions.
Topics: Age Factors; Animals; Autoradiography; Body Weight; Cannabinoid Receptor Modulators; Eating; Food Deprivation; Hyperphagia; Leptin; Limbic System; Male; Obesity; Piperidines; Pyrazoles; Rats; Rats, Zucker; Receptor, Cannabinoid, CB1; Receptors, Leptin; Rimonabant; Tritium; Up-Regulation | 2008 |
Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice.
Topics: Abdominal Fat; Adipocytes; Animals; Blood Glucose; Body Weight; Cannabinoid Receptor Antagonists; Dietary Fats; Extracellular Matrix; Gene Expression Regulation; Insulin; Leptin; Lipoproteins, VLDL; Mice; Mice, Inbred C57BL; Obesity; Piperidines; Pyrazoles; Rimonabant; Subcutaneous Fat; Transcription, Genetic | 2008 |
Involvement of adipokines in rimonabant-mediated insulin sensitivity in ob/ob mice.
Topics: Adipokines; Adiponectin; Adipose Tissue; Adipose Tissue, White; Animals; Anti-Obesity Agents; Blood Glucose; Body Weight; Down-Regulation; Female; Gene Expression; Glucose Intolerance; Glucose Tolerance Test; Insulin; Insulin Resistance; Leptin; Mice; Mice, Knockout; Models, Animal; Nicotinamide Phosphoribosyltransferase; Obesity; Organ Size; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Retinol-Binding Proteins, Plasma; Reverse Transcriptase Polymerase Chain Reaction; Rimonabant; RNA, Messenger; Tumor Necrosis Factor-alpha | 2009 |
The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice.
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzoxazines; Chlorocebus aethiops; Circadian Rhythm; COS Cells; Cyclohexanols; Dose-Response Relationship, Drug; Drinking Behavior; Dronabinol; Drug Administration Routes; Eating; Food Deprivation; Green Fluorescent Proteins; Hemoglobins; Hyperphagia; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Naphthalenes; Peptide Fragments; Piperidines; Protein Transport; Psychotropic Drugs; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Time Factors; Transfection | 2010 |
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity.
Topics: Animals; Insulin Resistance; Leptin; Liver; Male; Mice; Mice, Inbred C57BL; Morpholines; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Triglycerides | 2010 |
Weight loss induced by rimonabant is associated with an altered leptin expression and hypothalamic leptin signaling in diet-induced obese mice.
Topics: Analysis of Variance; Animals; Body Weight; Diet; Disease Models, Animal; Gene Expression Regulation; Hypothalamus; Leptin; Mice; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; RNA, Messenger; Signal Transduction | 2011 |
Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure.
Topics: Absorptiometry, Photon; Adiposity; Amides; Anti-Obesity Agents; Arachidonic Acids; Blood Glucose; Cannabinoid Receptor Modulators; Endocannabinoids; Energy Metabolism; Ethanolamines; Ethnicity; Glycerides; Humans; Insulin; Leptin; Palmitic Acids; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2011 |
Leptin potentiates the anti-obesity effects of rimonabant.
Topics: Animals; Anti-Obesity Agents; Dose-Response Relationship, Drug; Drug Synergism; Leptin; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Recurrence; Rimonabant; Ventromedial Hypothalamic Nucleus; Weight Loss | 2011 |
The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice.
Topics: Adiponectin; Adiposity; Animals; Anti-Obesity Agents; Biomarkers; Body Weight; Central Nervous System; Cholesterol; Diet, High-Fat; Energy Intake; Gastrointestinal Transit; Hypothermia; Insulin; Leptin; Mice; Mice, Knockout; Mice, Transgenic; MicroRNAs; Mutation; Obesity; Peripheral Nervous System; Phenotype; Piperidines; Promoter Regions, Genetic; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Triglycerides | 2011 |
Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice.
Topics: Animals; Calorimetry, Indirect; Eating; Energy Metabolism; Genetic Vectors; Hypothalamus; In Situ Hybridization, Fluorescence; Leptin; Male; Mice; Mice, Knockout; Piperidines; Pyrazoles; Real-Time Polymerase Chain Reaction; Receptor, Cannabinoid, CB1; Rimonabant | 2012 |
Developmental role for endocannabinoid signaling in regulating glucose metabolism and growth.
Topics: Animals; Cannabinoid Receptor Antagonists; Endocannabinoids; Glucose; Insulin; Insulin-Like Growth Factor I; Leptin; Liver; Mice; Mice, Knockout; Obesity; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Leptin; Rimonabant; Signal Transduction | 2013 |
Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.
Topics: Adiponectin; Adiposity; Animals; Body Weight; Cannabinoid Receptor Antagonists; Diet, High-Fat; Energy Intake; Fatty Liver; Leptin; Lipid Metabolism; Lipids; Liver; Mice; Mice, Knockout; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2014 |
Inhibition of Cannabinoid Receptor 1 Can Influence the Lipid Metabolism in Mice with Diet-Induced Obesity.
Topics: Adipose Tissue; Administration, Oral; Animals; Body Weight; Cannabinoid Receptor Antagonists; Carnitine O-Palmitoyltransferase; Cholesterol; Diet, High-Fat; Leptin; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Myocardium; Obesity; PPAR alpha; Receptor, Cannabinoid, CB1; Rimonabant | 2018 |